Patent intelligence · US
US 11332462
Heteroaryl compounds and methods of use thereof
Heteroaryl compounds and methods of use thereof
Patent details — US 11332462
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 17, 2022
- Expiration
- May 12, 2042
- Applicant
- PGI Drug Discovery LLC
- Claims
- 15
- CPC classes
- A61P, A61P1/08, A61P15/00, A61P15/10
Quick answer
US 11332462 (Heteroaryl compounds and methods of use thereof) is held by PGI Drug Discovery LLC. Status: granted. Granted May 17, 2022. Expires May 12, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- PGI Drug Discovery LLC
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61P, A61P1/08, A61P15/00, A61P15/10, A61P25/00, A61P25/04
More from PGI Drug Discovery LLC
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 11332462?
US 11332462 (Heteroaryl compounds and methods of use thereof) is held by PGI Drug Discovery LLC. Status: granted. Granted May 17, 2022. Expires May 12, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11332462?
PGI Drug Discovery LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 11332462 expire?
Our index shows an expiration date of May 12, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.